ÌÇÐÄ̽»¨

Uta was appointed to the Board of ÌÇÐÄ̽»¨ p.l.c. as a Non-Executive Director on 17 February 2025. She is a member of the Audit and Nominations Committees.

Uta brings notable transformational and M&A experience to the Board, in particular from the consumer goods and pharmaceutical sectors. Uta previously held the role of Chief Executive Officer, Personal Healthcare International at P&G. Prior to joining P&G, Uta had a 19 year career at Merck Group where she held several roles including Chief Executive Officer and President, Consumer Health Division, and Chief Executive Officer, Allergopharma and Global Business Unit Head, Allergy as well as Head of Corporate M&A, Treasury and Finance. Uta also spent time as a Senior Financial Auditor at Hoechst AG.

Uta is currently Non-Executive Director and Audit Chair of Beiersdorf AG, Non-Executive Director of Karo Healthcare AB (formerly Karo Pharma AB), Klosterfrau Healthcare Group and Schott AG,Ìý Director of Farco Pharma GmbH and advisory board member of Röchling SE & Co KG. She was previously a Non-Executive Director of Affimed N.V., Biotest AG and Gothaer Krankenversicherung and Allgemeine Versicherung.